Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Proteinuria

• Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
• Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
• Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease
• Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
• A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney
• Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria
• Empagliflozin in Patients With Glomerulonephritis
• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Childr
• Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy
• A Phase 2, Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
• Efficacy and Safety of Dapagliflozin in Children With Proteinuria
• Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
• Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury
• Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
• Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
• HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
• Safety and Efficacy of Two Year Spnol and Maximal R Blockad Therapy
• Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
• Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
• Availability Study of ACTH to Treat Children SRNS/SDNS
• Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury
• Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
• Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria
• Pharmacokinetics of Apixaban in Nephrotic Syndrome
• The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
• A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)
• Acthar on Proteinuria in IgA Nephropathy Patients
• Preventing Sickle Cell Kidney Disease
• Belatacept Conversion in Proteinuric Kidney Transplant Recipients
• Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
• Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria
• A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy
• Paricalcitol in Fabry Disease
• Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
• Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
• Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases
• A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
• Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease
• RAS Quantification in Patients With Aliskiren or Candesartan
• Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
• Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
• Minocycline and Proteinuria in Diabetic Nephropathy
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
• Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose
• FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
• Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
• MARCH Renal Substudy
• Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
• Renal Denervation in Diabetic Nephropathy
• Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
• The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria
• Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients
• Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients
• Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
• Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
• Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
• N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
• Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial
• Influence of Aliskiren on Proteinuria
• Velcade for Proliferative Lupus Nephritis
• Rituximab to Prevent Recurrence of Proteinuria
• Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
• Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
• Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
• Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
• Effect of Turmeric on Diabetic Nephropathy
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
• Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
• Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
• Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria
• The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
• Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
• The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria
• Sitaxsentan in Proteinuric Chronic Kidney Disease
• Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects
• Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis
• Study of Atorvastatin Dose Dependent Reduction of Proteinuria
• Endothelin Receptor Antagonism in Proteinuric Nephropathy
• Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients
• The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
• Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy
• Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
• Optimalization of Nephroprotection Using N-Acetylcysteine
• Optimalization of Nephroprotection Using Atorvastatin (Sortis)
• An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
• Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
• To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
• Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
• The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria
• Influence of Pioglitazone for Renal Transplant Function in Diabetics
• Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
• Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
• Statins and the Urinary Proteome
• The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
• Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
• Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
• Olmesartan Medoxomil and Diabetic Nephropathy
• Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
• Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
• Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
• High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
• Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
• Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)
• Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.
• Statins in Proteinuric Nephropathies
• Treatment Targets for Chronic Hypertension in Pregnancy
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
• Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria
• Angiotensin II Blockade for Chronic Allograft Nephropathy
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)